Repligen Corporation (RGEN)
NASDAQ: RGEN · Real-Time Price · USD
117.43
-0.86 (-0.73%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Repligen Stock Forecast
Stock Price Forecast
The 12 analysts with 12-month price forecasts for Repligen stock have an average target of 167.67, with a low estimate of 135 and a high estimate of 208. The average target predicts an increase of 42.78% from the current stock price of 117.43.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Repligen stock from 12 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 3 | 3 | 4 |
| Buy | 6 | 6 | 6 | 6 | 6 | 6 |
| Hold | 3 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 10 | 11 | 11 | 11 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $165 → $145 | Hold | Maintains | $165 → $145 | +23.48% | Apr 20, 2026 |
| Roth Capital | Roth Capital | Strong Buy Initiates $160 | Strong Buy | Initiates | $160 | +36.25% | Apr 17, 2026 |
| Barclays | Barclays | Buy Maintains $175 → $145 | Buy | Maintains | $175 → $145 | +23.48% | Apr 14, 2026 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $170 → $140 | Buy | Maintains | $170 → $140 | +19.22% | Apr 6, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $180 → $208 | Strong Buy | Maintains | $180 → $208 | +77.13% | Mar 23, 2026 |
Financial Forecast
Revenue This Year
843.84M
from 738.26M
Increased by 14.30%
Revenue Next Year
966.37M
from 843.84M
Increased by 14.52%
EPS This Year
2.00
from 0.86
Increased by 132.89%
EPS Next Year
2.54
from 2.00
Increased by 26.83%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 876.9M | 1.0B | ||||||
| Avg | 843.8M | 966.4M | ||||||
| Low | 804.0M | 902.6M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 18.8% | 20.6% | ||||||
| Avg | 14.3% | 14.5% | ||||||
| Low | 8.9% | 7.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 2.10 | 2.86 | ||||||
| Avg | 2.00 | 2.54 | ||||||
| Low | 1.89 | 1.83 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 144.2% | 42.6% | ||||||
| Avg | 132.9% | 26.8% | ||||||
| Low | 119.9% | -8.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.